After finishing at $4.38 in the prior trading day, Allogene Therapeutics Inc (NASDAQ: ALLO) closed at $4.26, down -2.74%. In other words, the price has decreased by -$0.1200 from its previous closing price. On the day, 1507678 shares were traded.
Ratios:
Our goal is to gain a better understanding of ALLO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.58 and its Current Ratio is at 12.58. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.18.
On December 08, 2023, Citigroup started tracking the stock assigning a Buy rating and target price of $7.Citigroup initiated its Buy rating on December 08, 2023, with a $7 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 30 ’24 when Parker Geoffrey M. bought 190 shares for $3.60 per share. The transaction valued at 683 led to the insider holds 819,590 shares of the business.
MESSEMER DEBORAH M. sold 18,640 shares of ALLO for $50,317 on Dec 18 ’23. The Director now owns 62,456 shares after completing the transaction at $2.70 per share. On Aug 07 ’23, another insider, Mayo Stephen, who serves as the Director of the company, sold 10,000 shares for $4.29 each. As a result, the insider received 42,855 and left with 25,328 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLO now has a Market Capitalization of 720.33M and an Enterprise Value of 366.76M. For the stock, the TTM Price-to-Sale (P/S) ratio is 4502.02 while its Price-to-Book (P/B) ratio in mrq is 1.23. Its current Enterprise Value per Revenue stands at 3.86k whereas that against EBITDA is -1.22.
Stock Price History:
Over the past 52 weeks, ALLO has reached a high of $6.89, while it has fallen to a 52-week low of $2.23. The 50-Day Moving Average of the stock is 4.2898, while the 200-Day Moving Average is calculated to be 3.8893.
Shares Statistics:
The stock has traded on average 2.87M shares per day over the past 3-months and 3.62M shares per day over the last 10 days, according to various share statistics. A total of 144.44M shares are outstanding, with a floating share count of 104.41M. Insiders hold about 38.28% of the company’s shares, while institutions hold 60.85% stake in the company. Shares short for ALLO as of Feb 29, 2024 were 25.01M with a Short Ratio of 8.71, compared to 23.09M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 14.86% and a Short% of Float of 21.88%.
Earnings Estimates
Its stock is currently analyzed by 12 different market analysts. On average, analysts expect EPS of -$0.4 for the current quarter, with a high estimate of -$0.22 and a low estimate of -$0.48, while EPS last year was -$0.68. The consensus estimate for the next quarter is -$0.39, with high estimates of -$0.23 and low estimates of -$0.47.
Analysts are recommending an EPS of between -$0.91 and -$2.1 for the fiscal current year, implying an average EPS of -$1.64. EPS for the following year is -$1.54, with 11 analysts recommending between -$0.24 and -$2.2.
